Data Sheet: GORE Protein Capture Device for Early Clinical Applications, 9.0mL (PROA103)

Data Sheets, English

The 9.0mL Device (PROA103) GORE Protein Capture Device provides performance advantages over traditional agarose resin columns in late stage discovery, pre-clinical and early clinical applications.

View as PDF (230.71 KB)

Contact Us

Americas

+1 800 294 4673

+1 410 506 1715

Europe

+49 89 4612 3456

+800 4612 3456

US

+1 800 294 4673

+1 410 506 1715

Contact by email

Chromatography News & Events

Press Release

GORE PHARMBIO INTRODUCES 250ML, 500ML AND 1L PROTEIN CAPTURE DEVICES WITH PROTEIN A TO DELIVER CONSISTENT SCALABILITY AND INCREASED PRODUCTIVITY ACROSS SIZES

Posted April 11, 2023

W. L. Gore & Associates, Inc. (“Gore”), a global materials science company, continues to build on its growing portfolio of protein capture devices with the introduction of its 250mL, 500mL and 1L GORE® Protein Capture Devices with Protein A. The offerings follow commer-cial availability of its 116mL and 232mL sizes introduced in mid 2022.

Event

Join W. L. Gore & Associates for the Live + Virtual Bioprocessing Summit Europe

March 14, 2023 - March 16, 2023

Join W. L. Gore & Associates at BioProcessing Summit Europe, Europe’s Premier Conference to Optimize Your Bioprocesses

Event

Visit GORE at BioProcess International in San Diego

February 27, 2023 - March 2, 2023

Join W. L. Gore & Associates for BioProcess International, the largest BioProcessing event for learning how to accelerate promising biologics, cell & gene therapies towards commercial success.

Top